{
  "claim_id": "claim_003",
  "claim": "Recombinant technology leads to a broader immune response that may provide cross-protection, even in a mismatch season.",
  "document": "CDC_Influenza_vaccines",
  "verified_evidence": [],
  "verification_stats": {
    "total_verified": 0
  }
}